Finding and assessing treatment effect sweet spots in clinical trial data.
暂无分享,去创建一个
[1] C. Holmes,et al. Machine learning analysis plans for randomised controlled trials: detecting treatment effect heterogeneity with strict control of type I error , 2020, Trials.
[2] R. Tibshirani,et al. An Approach to Explore for a Sweet-spot in Randomized Trials. , 2019, Journal of clinical epidemiology.
[3] James Watson,et al. Graphing and reporting heterogeneous treatment effects through reference classes , 2019, bioRxiv.
[4] Sören R. Künzel,et al. Metalearners for estimating heterogeneous treatment effects using machine learning , 2017, Proceedings of the National Academy of Sciences.
[5] S. Athey,et al. Generalized random forests , 2016, The Annals of Statistics.
[6] Matthew M. Chingos,et al. The Review of Economics and Statistics , 2018 .
[7] Susan Athey,et al. Recursive partitioning for heterogeneous causal effects , 2015, Proceedings of the National Academy of Sciences.
[8] Lu Tian,et al. Effectively Selecting a Target Population for a Future Comparative Study , 2013, Journal of the American Statistical Association.
[9] Kamolrat Silamut,et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial , 2010, The Lancet.
[10] David M Kent,et al. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal , 2010, Trials.
[11] M. Kenward,et al. An Introduction to the Bootstrap , 2007 .
[12] R. Tibshirani,et al. Pre-validation and inference in microarrays , 2002, Statistical applications in genetics and molecular biology.
[13] R. Tibshirani,et al. An Introduction to the Bootstrap , 1995 .